EGFR Signaling Is Required for TGF-β1–Mediated COX-2 Induction in Human Bronchial Epithelial Cells

M Liu, SC Yang, S Sharma, J Luo, X Cui… - American journal of …, 2007 - atsjournals.org
Cyclooxygenase-2 (COX-2) is a key enzyme in the production of prostaglandins and
thromboxanes from free arachidonic acid. Increasing evidence suggests that COX-2 plays a …

Prostaglandin E2 Activates Mitogen-Activated Protein Kinase/Erk Pathway Signaling and Cell Proliferation in Non–Small Cell Lung Cancer Cells in an Epidermal …

K Krysan, KL Reckamp, H Dalwadi, S Sharma… - Cancer research, 2005 - AACR
Abstract Cyclooxygenase 2 (COX-2) overexpression is found in a wide variety of human
cancers and is linked to all stages of tumorigenesis. Elevated tumor COX-2 expression is …

Co-expression of Cox-2 and EGFR in stage I human bronchial adenocarcinomas

K Araki, K Hashimoto, TD Ardyanto, M Osaki… - Lung Cancer, 2004 - Elsevier
Cyclooxygenase (Cox)-2 plays an important role in cell proliferation, carcinogenesis and
tumor growth, in part through the synthesis of prostaglandin E2 (PGE2) as well as through …

Targeting the eicosanoid pathway in non-small-cell lung cancer

L Horn, M Backlund, DH Johnson - Expert opinion on therapeutic …, 2009 - Taylor & Francis
Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) upregulation is an early
event in the development of non-small-cell lung cancer. Preclinical data indicate tumors with …

[HTML][HTML] Effects of COX-2 inhibition on expression of vascular endothelial growth factor and interleukin-8 in lung cancer cells

YM Zhu, NSM Azahri, DCW Yu, PJ Woll - BMC cancer, 2008 - Springer
Abstract Background Cyclooxygenase (COX)-2 has been implicated in tumour progression,
angiogenesis and metastasis in non-small cell lung cancer (NSCLC). We speculated that …

Cyclooxygenase as a target in lung cancer

JR Brown, RN DuBois - Clinical Cancer Research, 2004 - AACR
Preclinical studies suggest that cyclooxygenase (COX)-2 may be involved in the molecular
pathogenesis of some types of lung cancer. Most of the available studies point to its …

[HTML][HTML] Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer

H Luo, Z Chen, H Jin, M Zhuang, T Wang, C Su… - Journal of experimental …, 2011 - Springer
Background Vascular endothelial growth factor (VEGF) expression is up-regulated via a
cyclooxygenase-2 (COX-2)-dependent mechanism in non-small cell lung cancer (NSCLC) …

Synergistic induction of cyclooxygenase-2 by transforming growth factor-β1 and epidermal growth factor inhibits apoptosis in epithelial cells

D Saha, PK Datta, H Sheng, JD Morrow, M Wada… - Neoplasia, 1999 - Elsevier
Increased expression of cyclooxygenase-2 (COX-2) expression has been observed in
several human tumor types and in selected animal and cell culture models of …

Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic …

CM Richardson, RA Sharma, G Cox, KJ O'Byrne - Lung cancer, 2003 - Elsevier
The epidermal growth factor receptor (EGFR) is part of a family of plasma membrane
receptor tyrosine kinases that control many important cellular functions, from growth and …

Cyclooxygenase-2 Induces EP1- and HER-2/Neu-Dependent Vascular Endothelial Growth Factor-C Up-Regulation: A Novel Mechanism of Lymphangiogenesis in …

JL Su, JY Shih, ML Yen, YM Jeng, CC Chang… - Cancer research, 2004 - AACR
Abstract Cyclooxygenase (COX)-2, the inducible isoform of prostaglandin H synthase, has
been implicated in the progression of human lung adenocarcinoma. However, the …